表紙
市場調查報告書

骨移植、替代骨:開發平台分析

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 344260
出版日期 內容資訊 英文 513 Pages
訂單完成後即時交付
價格
骨移植、替代骨:開發平台分析 Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年10月11日內容資訊: 英文 513 Pages
簡介

本報告提供全球各國的企業、醫療機關等開發中的骨移植片及替代骨 (替代骨移植片) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各領域/各地區的詳細趨勢、各企業、各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 骨移植、替代骨:現在開發中的開發中產品 (各企業)

  • 骨移植、替代骨的開發企業:開發中產品 (各開發階段)
  • 骨移植、替代骨:各開發階段的開發中產品一覽

第5章 骨移植、替代骨的企業、產品概要

  • aap Implantate AG
    • 開發中產品及現在進行中的臨床實驗概要
  • Accelerated Orthopedic Technologies, Inc.
  • Adaptaide Inc.
  • Adocia
  • Advanced Biologics, LLC
  • Agenta Biotechnologies, Inc.
  • Allergan, Inc.
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Anika Therapeutics, Inc.
  • ApaTech Limited (Inactive)
  • Aperion Biologics Corporation
  • Arthro Kinetics AG
  • Aursos, Inc
  • Berkeley Advanced Biomaterials, Inc.
  • Bio2 Technologies, Inc.
  • Bioactive Bone Substitutes Ltd.
  • Bioregeneration Technologies, Inc
  • Bio-Scaffold International Pte Ltd
  • BioSET, Inc
  • Bioventus LLC
  • Body Organ Biomedical Corp.
  • Bone Solutions, Inc.
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Cellright Technologies, LLC
  • CeraPedics, Inc.
  • Chinese University of Hong Kong
  • Citrics Biomedical, LLC
  • CollPlant Ltd.
  • ConMed Corporation
  • CoreBone Ltd.
  • ElutInc
  • EpiBone
  • Exactech, Inc.
  • Graftoss Limited
  • Graftys SAS
  • Inion Oy
  • Innovia LLC
  • Innovoss Inc.
  • Integra LifeSciences Holdings Corporation
  • ISTO Technologies, Inc.
  • Jellagen Pty Ltd
  • kasios sas
  • Kensey Nash Corporation (Inactive)
  • Kytogenics Pharmaceuticals, Inc.
  • Lacerta Technologies GmbH
  • Mariel Therapeutics, Inc.
  • Maxigen Biotech Inc.
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • Miromatrix Medical Inc.
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • Noraker
  • NovaBone Products, LLC.
  • Nutech Medical, Inc
  • NuVasive, Inc.
  • Orthogen LLC
  • OssiFi, Inc.
  • OsteoNovus, LLC
  • PolyPid, Ltd.
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor, Inc.
  • RTI Surgical, Inc.
  • Sanofi
  • SIRAKOSS Limited
  • Soft Tissue Regeneration, Inc.
  • Soteira Inc.
  • Spineway
  • SurgaColl Technologies Ltd
  • TBF Genie Tissulaire
  • The Johns Hopkins University
  • Tissue Regeneration Systems, Inc.
  • Trinity College Dublin
  • University of California, San Diego
  • University of Edinburgh
  • University of Memphis
  • University of Nottingham's School Of Pharmacy
  • University of Pecs
  • University of South Florida
  • Wayne State University
  • Wound Management Technologies, Inc.
  • Wright Medical Group, Inc.
  • X-spine Systems, Inc.
  • Xtant Medical Holdings, Inc.

第6章 骨移植、替代骨:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0801EPD

GlobalData's Medical Devices sector report, "Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Bone Grafts and Substitutes Overview

3 Products under Development

  • 3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • 3.2 Bone Grafts and Substitutes - Pipeline Products by Segment
  • 3.3 Bone Grafts and Substitutes - Pipeline Products by Territory
  • 3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • 3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • 3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials

4 Bone Grafts and Substitutes - Pipeline Products under Development by Companies

  • 4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
  • 4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development

5 Bone Grafts and Substitutes Companies and Product Overview

  • 5.1 Adocia SAS Company Overview
  • 5.2 Aesculap Biologics LLC Company Overview
  • 5.3 Agenta Biotechnologies Inc (Inactive) Company Overview
  • 5.4 Alphatec Holdings Inc Company Overview
  • 5.5 Amend Surgical, Inc. Company Overview
  • 5.6 Anika Therapeutics Inc Company Overview
  • 5.7 Antibe Therapeutics Inc Company Overview
  • 5.8 Aperion Biologics Corp Company Overview
  • 5.9 Arthro Kinetics AG Company Overview
  • 5.10 Aursos, Inc (Inactive) Company Overview
  • 5.11 Baxter International Inc Company Overview
  • 5.12 Berkeley Advanced Biomaterials Inc Company Overview
  • 5.13 Bio2 Technologies Inc Company Overview
  • 5.14 Bioactive Bone Substitutes Plc Company Overview
  • 5.15 BioGend Therapeutics Co Ltd Company Overview
  • 5.16 BiolMed Innovations Pvt Ltd Company Overview
  • 5.17 Biomatlante SA Company Overview
  • 5.18 Bioregeneration Technologies, Inc Company Overview
  • 5.19 Biorez Inc Company Overview
  • 5.20 Bio-Scaffold International Pte Ltd Company Overview
  • 5.21 Bioventus LLC Company Overview
  • 5.22 Bone Solutions Inc Company Overview
  • 5.23 BoneGrafix, Inc. Company Overview
  • 5.24 BoneSupport AB Company Overview
  • 5.25 Bonus BioGroup Ltd Company Overview
  • 5.26 Calcitec, Inc. Company Overview
  • 5.27 Carmell Therapeutics Corp Company Overview
  • 5.28 Case Western Reserve University Company Overview
  • 5.29 CeraPedics Inc Company Overview
  • 5.30 Citrics Biomedical, LLC (Inactive) Company Overview
  • 5.31 Collagen Solutions Plc Company Overview
  • 5.32 Collplant Biotechnologies Ltd Company Overview
  • 5.33 ConMed Corp Company Overview
  • 5.34 curasan AG Company Overview
  • 5.35 Daewoong Pharmaceutical Co Ltd Company Overview
  • 5.36 Dimension Inx LLC Company Overview
  • 5.37 Drexel University Company Overview
  • 5.38 DSM Biomedical BV Company Overview
  • 5.39 Element Orthopedics Inc (Inactive) Company Overview
  • 5.40 ElutInc Company Overview
  • 5.41 Ember Therapeutics Inc (Inactive) Company Overview
  • 5.42 EpiBone Inc Company Overview
  • 5.43 Eskisehir Osmangazi University Company Overview
  • 5.44 EternoGen Aesthetics LLC Company Overview
  • 5.45 Exactech Inc Company Overview
  • 5.46 Ferring Pharmaceuticals AS Company Overview
  • 5.47 Gene Biotherapeutics Inc Company Overview
  • 5.48 Graftoss Limited Company Overview
  • 5.49 Graftys SA Company Overview
  • 5.50 Hospital for Special Surgery Company Overview
  • 5.51 Induce Biologics Inc. Company Overview
  • 5.52 Innovoss Inc. (Inactive) Company Overview
  • 5.53 IRCCS San Raffaele Hospital Company Overview
  • 5.54 Isto Biologics Company Overview
  • 5.55 Johns Hopkins University Company Overview
  • 5.56 kasios sas Company Overview
  • 5.57 King's College London Company Overview
  • 5.58 Kuros Biosciences AG Company Overview
  • 5.59 Kytogenics Pharmaceuticals Inc Company Overview
  • 5.60 Lattice Biologics Ltd Company Overview
  • 5.61 Locate Bio Ltd Company Overview
  • 5.62 Maxigen Biotech Inc Company Overview
  • 5.63 Medisse BV (Inactive) Company Overview
  • 5.64 Medtronic plc Company Overview
  • 5.65 Miromatrix Medical Inc Company Overview
  • 5.66 N2 Biomedical Company Overview
  • 5.67 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
  • 5.68 National University of Science and Technology MiSiS Company Overview
  • 5.69 NovaBone Products LLC Company Overview
  • 5.70 Nutech Medical Inc Company Overview
  • 5.71 Oligo Medic Inc Company Overview
  • 5.72 Orthocell Ltd Company Overview
  • 5.73 OrthoMedex LLC Company Overview
  • 5.74 OrthoPediatrics Corp Company Overview
  • 5.75 Orthosera GmbH Company Overview
  • 5.76 Osiris Therapeutics Inc Company Overview
  • 5.77 OssiFi, Inc. Company Overview
  • 5.78 OsteoNovus, LLC Company Overview
  • 5.79 PolyPid Ltd Company Overview
  • 5.80 Polytechnic University of Catalonia Company Overview
  • 5.81 Promimic AB Company Overview
  • 5.82 ReCaPP Company Overview
  • 5.83 RepRegen Ltd. (Inactive) Company Overview
  • 5.84 Revivicor Inc Company Overview
  • 5.85 RTI Surgical Inc Company Overview
  • 5.86 Sanara MedTech Inc Company Overview
  • 5.87 Scil Technology GmbH Company Overview
  • 5.88 SeaSpine, Inc. Company Overview
  • 5.89 SIRAKOSS Ltd Company Overview
  • 5.90 Sofregen Medical Inc Company Overview
  • 5.91 Soteira Inc Company Overview
  • 5.92 SurgaColl Technologies Ltd Company Overview
  • 5.93 T&R Biofab Co Ltd Company Overview
  • 5.94 TBF Genie Tissulaire Company Overview
  • 5.95 The Chinese University of Hong Kong Company Overview
  • 5.96 Theragnostic Technologies Inc Company Overview
  • 5.97 Tissue Regeneration Systems, Inc. Company Overview
  • 5.98 Trinity College Dublin Company Overview
  • 5.99 University of California San Diego Company Overview
  • 5.100 University of Edinburgh Company Overview
  • 5.101 University of Malaya Company Overview
  • 5.102 University of Maryland Company Overview
  • 5.103 University of Memphis Company Overview
  • 5.104 University of Pecs Company Overview
  • 5.105 University of South Florida Company Overview
  • 5.106 Vanderbilt University Company Overview
  • 5.107 Wayne State University Company Overview
  • 5.108 Wright Medical Group NV Company Overview
  • 5.109 Xtant Medical Holdings Inc Company Overview

6 Bone Grafts and Substitutes- Recent Developments

  • 6.1 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
  • 6.2 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
  • 6.3 Sep 24, 2019: Kuros Biosciences announces full commercial launch of MagnetOs and exhibitor status at North American Spine Society 34th Annual Meeting
  • 6.4 Sep 24, 2019: Bone Bank Allografts launches global sales force initiative
  • 6.5 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors
  • 6.6 Sep 19, 2019: Medicrea reports first half 2019 financial results
  • 6.7 Sep 04, 2019: Biogennix Launches Agilon Bone Grafting Solution
  • 6.8 Aug 30, 2019: Bone Therapeutics reports half year 2019 results
  • 6.9 Aug 30, 2019: BBS Interim Report H1/2019
  • 6.10 Aug 29, 2019: Lattice Biologics reports third quarter 2019 results
  • 6.11 Aug 28, 2019: BONESUPPORT announces partnership with Academy Medical
  • 6.12 Aug 28, 2019: Medtronic announces planned leadership succession
  • 6.13 Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit
  • 6.14 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly
  • 6.15 Aug 21, 2019: BONESUPPORT HOLDING announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
  • 6.16 Aug 21, 2019: NuVasive: Departure of directors or certain officers
  • 6.17 Aug 20, 2019: Kuros Biosciences reports results for first half 2019
  • 6.18 Aug 20, 2019: Medtronic reports first quarter financial results for 2019

7.Appendix

List of Tables

  • Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 24
  • Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment 25
  • Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory 26
  • Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 27
  • Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 28
  • Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 29
  • Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 30
  • Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 33
  • Table 9: Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 10: BioChaperone BMP - Degenerative Disc Disease - Product Status 38
  • Table 11: BioChaperone BMP - Degenerative Disc Disease - Product Description 39
  • Table 12: Biochaperone BMP - Non-Union Fractures - Product Status 39
  • Table 13: Biochaperone BMP - Non-Union Fractures - Product Description 39
  • Table 14: BioChaperone BMP - Osteoporosis - Product Status 40
  • Table 15: BioChaperone BMP - Osteoporosis - Product Description 40
  • Table 16: Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 17: NOVOCART DISC - Product Status 41
  • Table 18: NOVOCART DISC - Product Description 41
  • Table 19: Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 20: B-247 Cranial Bone Graft Implant - Product Status 42
  • Table 21: B-247 Cranial Bone Graft Implant - Product Description 42
  • Table 22: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 23: Alphatec Neocore Osteoconductive Matrix - Product Status 43
  • Table 24: Alphatec Neocore Osteoconductive Matrix - Product Description 43
  • Table 25: Bonex - Product Status 44
  • Table 26: Bonex - Product Description 44
  • Table 27: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 28: Biomimetic Bone - Product Status 45
  • Table 29: Biomimetic Bone - Product Description 45
  • Table 30: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 31: Hyalobone - Product Status 46
  • Table 32: Hyalobone - Product Description 46
  • Table 33: Hyalofast - Product Status 47
  • Table 34: Hyalofast - Product Description 47
  • Table 35: Hyalograft C Autograft - Product Status 47
  • Table 36: Hyalograft C Autograft - Product Description 48
  • Table 37: Anika Therapeutics Inc - Ongoing Clinical Trials Overview 49
  • Table 38: Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 50
  • Table 39: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 40: CGX-227 - Product Status 51
  • Table 41: CGX-227 - Product Description 51
  • Table 42: CGX-443 - Product Status 52
  • Table 43: CGX-443 - Product Description 52
  • Table 44: Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 45: Z-Fix - Product Status 53
  • Table 46: Z-Fix - Product Description 53
  • Table 47: Z-Meniscus - Product Status 54
  • Table 48: Z-Meniscus - Product Description 54
  • Table 49: Z-Patch - Product Status 54
  • Table 50: Z-Patch - Product Description 55
  • Table 51: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 52: CaReS plus - Product Status 56
  • Table 53: CaReS plus - Product Description 56
  • Table 54: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 55: AUR-84 Resorbable Implant - Product Status 57
  • Table 56: AUR-84 Resorbable Implant - Product Description 57
  • Table 57: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 58: Synthetic Bone Graft - Spinal - Product Status 58
  • Table 59: Synthetic Bone Graft - Spinal - Product Description 58
  • Table 60: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 61: CPA Ceramics - Product Status 59
  • Table 62: CPA Ceramics - Product Description 59
  • Table 63: HAP Ceramics - Product Status 60
  • Table 64: HAP Ceramics - Product Description 60
  • Table 65: Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 66: Vitrium - Hammertoe Correction - Product Status 61
  • Table 67: Vitrium - Hammertoe Correction - Product Description 61
  • Table 68: Vitrium - Radial Osteotomy - Product Status 62
  • Table 69: Vitrium - Radial Osteotomy - Product Description 62
  • Table 70: Vitrium - Wrist Fracture Revision - Product Status 62
  • Table 71: Vitrium - Wrist Fracture Revision - Product Description 63
  • Table 72: Bioactive Bone Substitutes Plc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 73: ARTEBONE - Product Status 64
  • Table 74: ARTEBONE - Product Description 64
  • Table 75: Bone Graft Substitute - Blocks - Product Status 65
  • Table 76: Bone Graft Substitute - Blocks - Product Description 65
  • Table 77: Bone Graft Substitute - Granules - Product Status 65
  • Table 78: Bone Graft Substitute - Granules - Product Description 66
  • Table 79: BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 80: OIF - Non-Union Bone Fracture - Product Status 67

List of Figures

  • Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 24
  • Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment 25
  • Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory 26
  • Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 27
  • Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 28
  • Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 29